Tetrathiomolybdate as an antiangiogenesis therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration.
about
Tetrathiomolybdate as an antiangiogenesis therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Tetrathiomolybdate as an antia ...... -related macular degeneration.
@ast
Tetrathiomolybdate as an antia ...... -related macular degeneration.
@en
Tetrathiomolybdate as an antia ...... -related macular degeneration.
@nl
type
label
Tetrathiomolybdate as an antia ...... -related macular degeneration.
@ast
Tetrathiomolybdate as an antia ...... -related macular degeneration.
@en
Tetrathiomolybdate as an antia ...... -related macular degeneration.
@nl
prefLabel
Tetrathiomolybdate as an antia ...... -related macular degeneration.
@ast
Tetrathiomolybdate as an antia ...... -related macular degeneration.
@en
Tetrathiomolybdate as an antia ...... -related macular degeneration.
@nl
P2860
P1476
Tetrathiomolybdate as an antia ...... e-related macular degeneration
@en
P2093
Andrew K Vine
George J Brewer
P2860
P304
73-6; discussion 76-7
P577
2002-01-01T00:00:00Z